The proliferation of substandard medicines represents a deeply concerning challenge facing the global public health landscape. These fraudulent products, often mimicking legitimate medications, pose a significant danger to patient safety, undermining treatment effectiveness and potentially leading to severe harmful health consequences. Motivated by